Clinical Trial Update: Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Critical Limb Ischemia [Phase 2]

View source ↗

Summary

Phase 2 study evaluating JVS-100 in adults with critical limb ischemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia

Drugs mentioned

• JVS-100

Snippet

Sponsor: Juventas Therapeutics, Inc. | Conditions: Critical Limb Ischemia | Phase 2 | Status: COMPLETED